Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 14 (1) , 55-61
- https://doi.org/10.2165/00002512-199914010-00004
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal WomenNew England Journal of Medicine, 1997
- Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogensThe Lancet, 1996
- Risk of venous thromboembolism in users of hormone replacement therapyThe Lancet, 1996
- Prospective study of exogenous hormones and risk of pulmonary embolism in womenThe Lancet, 1996
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Review papers : The statistical basis of meta-analysisStatistical Methods in Medical Research, 1993
- Perimenopausal hormone replacement therapy: Review of the literatureJournal of Nurse-Midwifery, 1991
- Cardiovascular implications of estrogen replacement therapyInternational Journal of Gynecology & Obstetrics, 1990